M2 Group scores $6M for devices to treat diabetes
M2 Group Holdings, maker of disposable medical devices used to deliver medication for Type 1 diabetes, has raised $6 million of an anticipated $10 million round of equity, according to regulatory filings. Based in Sunnyvale, Calif., the company has previously been backed by Thomas McNerney & Partners.
Next Story: Portaero still looking for $182K to treat emphysema
Previous Story: Greentech Media raises $825K to fund new services
About the Author, Camille Ricketts
Camille was the lead writer for GreenBeat until August 2010. To reach VentureBeat's current writers, email tips@venturebeat.com.
